Krysta Chaldekas
Georgetown University(US)Georgetown University Medical Center(US)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Epigenetics and DNA Methylation, Breast Cancer Treatment Studies, Esophageal Cancer Research and Treatment
Most-Cited Works
- → Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion(2021)380 cited
- → Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis(2017)157 cited
- → STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non–Muscle-Invasive Bladder Cancer(2018)32 cited
- → The tumor immune microenvironment of primary and metastatic HER2− positive breast cancers utilizing gene expression and spatial proteomic profiling(2021)29 cited
- → Clinicopathologic and Prognostic Significance of LGR5, a Cancer Stem Cell Marker in Patients With Colorectal Cancer(2019)18 cited
- → A Prospective Analysis of Quality of Life and Toxicity Outcomes in Treating Early Breast Cancer With Breast Conservation Therapy and Intraoperative Radiation Therapy(2018)16 cited
- → The orphan nuclear receptor estrogen-related receptor beta (ERRβ) in triple-negative breast cancer(2019)15 cited
- → STAG2 as a prognostic biomarker in low-grade non-muscle invasive bladder cancer(2021)14 cited
- → A comparison study of the intratumoral microbiome in younger verses older-onset colorectal cancer (COSMO CRC).(2020)5 cited
- → Identification of STAG2-Mutant Bladder Cancers by Immunohistochemistry(2023)2 cited